The answer to genetic blindness begins with a CLEAR VISION

AGTC’s Clarity Clinical Trials are research studies that are exploring potentially life-changing treatments for rare genetic eye disorders, including achromatopsia. learn About our trials
Text size A A

Join Us In Groundbreaking Achromatopsia Research

In rare inherited disorders like achromatopsia, patients are critical partners in research. If you are interested in joining one of our trials and advancing this work, we look forward to hearing from you!

About our trials

There’s really good work being done in trials for achromatopsia, and I’m hopeful they’ll see results in the future.

- ACHROMATOPSIA PATIENT JOURNEY SURVEY RESPONDENT
Interested in AGTC’s Clarity Clinical Trials? Contact Us
Our Trials

Clarity Trials for Achromatopsia

AGTC’s Clarity Clinical Trials are studying gene therapies, which are treatments that replace a mutated gene with a working copy of the same gene. The purpose of our research is to test whether the gene therapies are safe and to see if they can improve vision and other symptoms of achromatopsia.

NOW ENROLLING

CNGB3STUDY

To assess the safety and efficacy of an experimental gene therapy for people, currently between the ages of 4-8 years old, with achromatopsia caused by a mutation in the CNGB3 gene

NOW ENROLLING

CNGA3STUDY

To assess the safety and efficacy of an experimental gene therapy for people, currently between the ages of 4-8 years old, with achromatopsia caused by a mutation in the CNGA3 gene

Learn more About Achromatopsia
Be a part of finding a treatment for achromatopsia Join Us